KBC Group
HHS icon

KBC Group’s Harte-Hanks HHS Stock Holding History

KBC Group’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,381
Closed -$111K – 1301
2016
Q1 		$111K Sell
4,381
-76
-2% -$2.33K ﹤0.01% 1136
2015
Q4 		$144K Buy
4,457
+3,255
+271% +$122K ﹤0.01% 1056
2015
Q3 		$42K Sell
1,202
-347
-22% -$15.7K ﹤0.01% 1250
2015
Q2 		$92K Sell
1,549
-1,518
-49% -$102K ﹤0.01% 1267
2015
Q1 		$239K Buy
3,067
+207
+7% +$16K ﹤0.01% 1091
2014
Q4 		$221K Buy
2,860
+318
+13% +$20.8K ﹤0.01% 1172
2014
Q3 		$162K Buy
2,542
+1,725
+211% +$117K 0.01% 1043
2014
Q2 		$59K Buy
817
+416
+104% +$32.1K ﹤0.01% 1260
2014
Q1 		$35K Sell
401
-1,584
-80% -$123K ﹤0.01% 1230
2013
Q4 		$155K Buy
1,985
+1,445
+268% +$118K ﹤0.01% 1061
2013
Q3 		$48K Sell
540
-1,477
-73% -$135K ﹤0.01% 1172
2013
Q2 		$173K Buy
+2,017
New +$167K ﹤0.01% 1020

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KBC Group's HHS Position: Q2 2016 in Review

KBC Group sold out of Harte-Hanks (HHS) in Q2 2016, closing a stake of 4,381 shares — an estimated $111K sold.

KBC Group first reported a position in HHS in Q2 2013 and held it in 12 quarters. The position peaked at $239K in Q1 2015. 107 funds tracked by Wall St. Rank hold HHS as of Q2 2016.

  • KBC Group reported no remaining Harte-Hanks position as of Q2 2016 after selling out during the quarter.
  • KBC Group sold 4,381 Harte-Hanks shares in Q2 2016, an estimated $111K.
  • KBC Group first reported a position in Harte-Hanks in Q2 2013 and held it in 12 quarters.
  • KBC Group's Harte-Hanks position peaked at $239K in Q1 2015.
  • 107 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2016.

Based on KBC Group's 13F filing for Q2 2016, filed 3 Aug 2016.